Literature DB >> 26962102

ACTH action on podocytes: mystery solved?

Paolo Cravedi1, Kirk N Campbell2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26962102      PMCID： PMC4971891          DOI： 10.1152/ajprenal.00139.2016

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN： 1522-1466


× No keyword cloud information.
  11 in total

1.  Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.

Authors:  Alessia Fornoni; Junichiro Sageshima; Changli Wei; Sandra Merscher-Gomez; Robier Aguillon-Prada; Alexandra N Jauregui; Jing Li; Adela Mattiazzi; Gaetano Ciancio; Linda Chen; Gaston Zilleruelo; Carolyn Abitbol; Jayanthi Chandar; Wacheree Seeherunvong; Camillo Ricordi; Masami Ikehata; Maria Pia Rastaldi; Jochen Reiser; George W Burke
Journal:  Sci Transl Med       Date:  2011-06-01       Impact factor: 17.956

2.  Melanocortin 1 receptor agonists reduce proteinuria.

Authors:  Annika Lindskog; Kerstin Ebefors; Martin E Johansson; Bergur Stefánsson; Anna Granqvist; Margret Arnadottir; Anna-Lena Berg; Jenny Nyström; Börje Haraldsson
Journal:  J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 10.121

3.  A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.

Authors:  Claudio Ponticelli; Patrizia Passerini; Maurizio Salvadori; Carlo Manno; Battista Fabio Viola; Sonia Pasquali; Salvatore Mandolfo; Piergiorgio Messa
Journal:  Am J Kidney Dis       Date:  2006-02       Impact factor: 8.860

4.  Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy.

Authors:  A L Berg; P Nilsson-Ehle; M Arnadottir
Journal:  Kidney Int       Date:  1999-10       Impact factor: 10.612

5.  Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization.

Authors:  Richard F Ransom; Nancy G Lam; Mark A Hallett; Simon J Atkinson; William E Smoyer
Journal:  Kidney Int       Date:  2005-12       Impact factor: 10.612

Review 6.  Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.

Authors:  Regina Berkovich; Mark A Agius
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

7.  Melanocortin 1 receptor agonist protects podocytes through catalase and RhoA activation.

Authors:  Johannes Elvin; Lisa Buvall; Annika Lindskog Jonsson; Anna Granqvist; Emelie Lassén; Lovisa Bergwall; Jenny Nyström; Börje Haraldsson
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-17

8.  The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

Authors:  Christian Faul; Mary Donnelly; Sandra Merscher-Gomez; Yoon Hee Chang; Stefan Franz; Jacqueline Delfgaauw; Jer-Ming Chang; Hoon Young Choi; Kirk N Campbell; Kwanghee Kim; Jochen Reiser; Peter Mundel
Journal:  Nat Med       Date:  2008-09       Impact factor: 53.440

9.  Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.

Authors:  Piero Ruggenenti; Hanna Debiec; Barbara Ruggiero; Antonietta Chianca; Timothee Pellé; Flavio Gaspari; Flavio Suardi; Elena Gagliardini; Silvia Orisio; Ariela Benigni; Pierre Ronco; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2015-03-24       Impact factor: 10.121

Review 10.  Nonimmunologic targets of immunosuppressive agents in podocytes.

Authors:  Tae-Hyun Yoo; Alessia Fornoni
Journal:  Kidney Res Clin Pract       Date:  2015-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.